Abnova and Clearbridge BioMedics Accelerate Circulating Tumor Cell System into
the Research and In Vitro Diagnostic Markets
19-Sep-2011 -
Abnova Corporation and Clearbridge BioMedics announced a collaboration to jointly develop a platform that provides a next generation, non-invasive “liquid biopsy” for cancer screening, staging, treatment, and monitoring. Through this collaboration, Abnova will leverage upon Clearbridge BioMedics’ ...
antibodies
cancer screening